Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/32542
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Community-acquired pneumonia |
Author: | Johnson, P. Irving, L. Turnidge, J. |
Citation: | Medical Journal of Australia, 2002; 176(7):341-347 |
Publisher: | Australasian Med Publ Co Ltd |
Issue Date: | 2002 |
ISSN: | 0025-729X 1326-5377 |
Statement of Responsibility: | Paul D R Johnson, Lou B Irving, John D Turnidge |
Abstract: | Community-acquired pneumonia is caused by a range of organisms, most commonly Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae and respiratory viruses. Chest x-ray is required for diagnosis. A risk score based on patient age, coexisting illness, physical signs and results of investigations can aid management decisions. Patients at low risk can usually be managed with oral antibiotics at home, while those at higher risk should be further assessed, and may need admission to hospital and intravenous therapy. For S. pneumoniae infection, amoxycillin is the recommended oral drug, while benzylpenicillin is recommended for intravenous use; all patients should also receive a tetracycline (eg, doxycycline) or macrolide (eg, roxithromycin) as part of initial therapy. Flucloxacillin or dicloxacillin should be added if staphylococcal pneumonia is suspected, and gentamicin or other specific therapy if gram-negative pneumonia is suspected; a third-generation cephalosporin plus intravenous erythromycin is recommended as initial therapy for severe cases. Infections that require special therapy should be considered (eg, tuberculosis, melioidosis, Legionella, Acinetobacter baumanii and Pneumocystis carinii infection). |
Keywords: | Humans Community-Acquired Infections Pneumonia Anti-Bacterial Agents Diagnosis, Differential Severity of Illness Index Risk Factors Evidence-Based Medicine Penicillin Resistance Aged Male |
Description: | The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included. |
DOI: | 10.5694/j.1326-5377.2002.tb04437.x |
Published version: | http://www.mja.com.au/public/issues/176_07_010402/joh10289_fm.html |
Appears in Collections: | Aurora harvest Molecular and Biomedical Science publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_32542.pdf | Published version | 1.48 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.